Related Experiment Video
Updated: Jan 13, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
When heme is low, copper kills cancer.
1Department of Medicine V, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany; Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany; Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Low heme levels destabilize respiratory chain complex IV, releasing copper and inducing cell death via cuproptosis in acute myeloid leukemia. This finding reveals a novel mechanism for targeting cancer cells.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Heme is essential for oxygen transport and redox reactions.
- Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow.
- Cuproptosis is a copper-dependent cell death pathway.
Purpose of the Study:
- To investigate the role of heme in regulating mitochondrial function and cell death in AML.
- To elucidate the mechanism by which low heme concentrations affect cancer cells.
Main Methods:
- The study by Lewis and Gruber et al. utilized biochemical assays to analyze mitochondrial respiratory chain complexes.
- Cellular models of acute myeloid leukemia were employed to study cell viability and death pathways.
- Copper levels and the process of cuproptosis were specifically monitored.
Main Results:
- Low concentrations of heme were found to destabilize complex IV of the respiratory chain.
- This destabilization led to the release of copper within the cell.
- The released copper triggered a potent form of cell death known as cuproptosis in AML cells.
Conclusions:
- Heme concentration is a critical regulator of mitochondrial integrity and cell fate.
- Targeting heme metabolism or copper-induced cuproptosis presents a potential therapeutic strategy for AML.
- This research uncovers a novel vulnerability in acute myeloid leukemia cells exploitable for treatment.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Hematopoietic Stem Cells
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

